You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastro-esophageal junction cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • CS1001 monoclonal antibody
  • +3 more
  • Beijing, China
    Beijing Cancer Hospital
Sep 27, 2022

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

Completed
  • Squamous Cell Carcinoma
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer Trial in Seoul (autologous activated T

Recruiting
  • Relapsed or Advanced Gastric Adenocarcinoma
  • Gastro-esophageal Junction Cancer
  • autologous activated T lymphocyte
  • Seoul, Korea, Republic of
    Gangnam Severacen Hospital
Sep 15, 2021

Gastric Cancer, Gastro-oesophageal Junction Cancer, Immunotherapy Trial in Shanghai (Anlotinib Plus Toripalimab)

Recruiting
  • Gastric Cancer
  • +4 more
  • Anlotinib Plus Toripalimab
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Dec 28, 2020

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

Active, not recruiting
  • Adenocarcinoma of the Esophagus
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022

Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85

Active, not recruiting
  • Gastro-Esophageal Junction Adenocarcinoma
  • Gastric Cancer
  • Nab-paclitaxel 150 mg/m^2
  • +3 more
  • Chicago, Illinois
  • +7 more
Feb 16, 2022

Stomach Cancer, Gastro Esophageal Junction Cancer Trial in Amsterdam, Eindhoven (Atezolizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Stomach Cancer
  • Gastro Esophageal Junction Cancer
  • Amsterdam, Netherlands
  • +1 more
Apr 19, 2021

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +7 more
  • Duarte, California
  • +30 more
Jan 7, 2023

Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Seoul, Korea, Republic of
    Severance Hospital
Aug 29, 2021

Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • (no location specified)
Jun 12, 2023

Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer Trial in Kashiwa (Zolbetuximab)

Completed
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Kashiwa, Chiba, Japan
    Site JP00001
Mar 3, 2021

Clinical & Pathological Studies of Upper Gastrointestinal

Recruiting
  • Stomach Cancer
  • +4 more
  • Blood draw
  • Tissue tumor biopsy
  • Stanford, California
    Stanford University School of Medicine
Jul 29, 2021

Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

Recruiting
  • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Mar 9, 2022

Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2

Recruiting
  • Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
  • Duarte, California
  • +12 more
Jul 6, 2022

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Oesophageal Carcinoma Trial in Australia (APR-246)

Terminated
  • Oesophageal Carcinoma
  • Clayton, Victoria, Australia
  • +4 more
Dec 10, 2021

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Gastric Cancer, Esophageal Cancer Trial (FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System)

Not yet recruiting
  • Gastric Cancer
  • Esophageal Cancer
  • FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System
  • (no location specified)
Jun 2, 2023

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Trial in Guangzhou (zolbetuximab)

Completed
  • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
  • Guangzhou, China
    Site CN86001
Jan 11, 2022

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Minimally Invasive Surgery of the Gastro-esophageal Junction

Recruiting
  • Achalasia
  • +4 more
    • Ottawa, Ontario, Canada
      Ottawa Hospital Research Institute
    Mar 21, 2022

    Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction Trial in Amsterdam (Docetaxel, Oxaliplatin,

    Active, not recruiting
    • Metastatic Gastric Cancer
    • Adenocarcinoma of the Gastro-oesophageal Junction
    • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab
    • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Jan 26, 2021